MedTrace Logo

Norwegian Spontaneous Coronary Artery Dissection Study

NCT07317323 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-01-05

No results posted yet for this study

Summary

The Norwegian Spontaneous Coronary Artery Dissection Study (NOR-SCAD) is a national, multicenter prospective observational study conducted at major hospitals in Norway. The study investigates risk factors and complications of spontaneous coronary artery dissection (SCAD). Patients aged 18 years or older who are hospitalized with SCAD are recruited during the index hospitalization. Each participant will be followed for 52 weeks with scheduled visits at 8 and 12 weeks and a final phone call at 52 weeks. Evaluations include coronary CT angiography (CTA), cardiac assessments, genetic analyses, blood sampling, structured questionnaires, and a cardiopulmonary exercise test (CPET).

Conditions

  • SCAD
  • Myocardial Infarction (MI)
  • Women

Sponsors & Collaborators

  • University Hospital, Akershus

    collaborator OTHER

  • Haukeland University Hospital, Bergen, Norway

    collaborator UNKNOWN

  • Sorlandet Hospital HF

    collaborator OTHER_GOV

  • Universitetssykehuset i Nord-Norge HF

    collaborator UNKNOWN

  • Ullevaal University Hospital

    collaborator OTHER

  • Helse Stavanger HF

    collaborator OTHER_GOV

  • St.Olavs Hospital, Trondheim University Hospital, Norway

    collaborator UNKNOWN

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Mette Elise Estensen, MD., PhD · ProCardio, Kardiologisk avdeling Rikshospitalet, Oslo Univeristy Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2035-12-31
Completion
2035-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07317323 on ClinicalTrials.gov